LH Laboratory Corp Of America Holdings

  1. Stocks
  2. Healthcare
  3. NYSE: LH

Price (delayed)

$243.735

Market cap

$22.59B

P/E Ratio

11.09

Dividend/share

$0.72

EPS

$21.98

Enterprise value

$27.65B

Laboratory Corporation of America Holdings, more commonly known as LabCorp, is an American S&P 500 company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks ...

Highlights
The price to earnings (P/E) is 38% lower than the 5-year quarterly average of 18.0
The quick ratio has grown by 14% YoY
LH's net income is down by 21% YoY and by 12% from the previous quarter
Laboratory Corp Of America Holdings's EPS has decreased by 19% YoY and by 11% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.labcorp.com
Peers: DGX NEO ENZ BRLI

Key stats

What are the main financial stats of LH
Market
Shares outstanding
92.7M
Market cap
$22.59B
Enterprise value
$27.65B
Valuations
Price to earnings (P/E)
11.09
Price to book (P/B)
2.12
Price to sales (P/S)
1.44
EV/EBIT
9.38
EV/EBITDA
7.15
EV/Sales
1.74
Earnings
Revenue
$15.86B
EBIT
$2.95B
EBITDA
$3.87B
Free cash flow
$1.83B
Per share
EPS
$21.98
Free cash flow per share
$19.55
Book value per share
$114.79
Revenue per share
$169.8
TBVPS
$91.97
Balance sheet
Total assets
$20.73B
Total liabilities
$9.99B
Debt
$6.29B
Equity
$10.72B
Working capital
$2.59B
Liquidity
Debt to equity
0.59
Current ratio
1.98
Quick ratio
1.62
Net debt/EBITDA
1.31
Margins
EBITDA margin
24.4%
Gross margin
33.2%
Net margin
13.2%
Operating margin
18.2%
Efficiency
Return on assets
10.2%
Return on equity
20.1%
Return on invested capital
27.4%
Return on capital employed
16.3%
Return on sales
18.6%
Dividend
Dividend yield
0.3%
DPS
$0.72
Payout ratio
3.3%

LH stock price

How has the Laboratory Corp Of America Holdings stock price performed over time
Intraday
-0.06%
1 week
4%
1 month
-0.71%
1 year
-13.34%
YTD
-22.43%
QTD
4%

Financial performance

How have Laboratory Corp Of America Holdings's revenue and profit performed over time
Revenue
$15.86B
Gross profit
$5.26B
Operating income
$2.89B
Net income
$2.1B
Gross margin
33.2%
Net margin
13.2%
The net margin has declined by 24% year-on-year and by 10% since the previous quarter
The operating margin has contracted by 24% YoY and by 10% from the previous quarter
Laboratory Corp Of America Holdings's operating income has decreased by 22% YoY and by 11% QoQ
LH's net income is down by 21% YoY and by 12% from the previous quarter

Growth

What is Laboratory Corp Of America Holdings's growth rate over time

Valuation

What is Laboratory Corp Of America Holdings stock price valuation
P/E
11.09
P/B
2.12
P/S
1.44
EV/EBIT
9.38
EV/EBITDA
7.15
EV/Sales
1.74
The price to earnings (P/E) is 38% lower than the 5-year quarterly average of 18.0
Laboratory Corp Of America Holdings's EPS has decreased by 19% YoY and by 11% QoQ
The P/B is 18% lower than the last 4 quarters average of 2.6 and 8% lower than the 5-year quarterly average of 2.3
The company's equity rose by 7% YoY and by 4.4% QoQ
LH's price to sales (P/S) is 15% lower than its last 4 quarters average of 1.7 and 4% lower than its 5-year quarterly average of 1.5
LH's revenue is up by 3.5% year-on-year

Efficiency

How efficient is Laboratory Corp Of America Holdings business performance
LH's ROE is down by 33% YoY and by 13% QoQ
LH's ROA is down by 26% YoY and by 12% QoQ
The company's return on invested capital fell by 24% YoY and by 14% QoQ
Laboratory Corp Of America Holdings's return on sales has decreased by 23% YoY and by 10% QoQ

Dividends

What is LH's dividend
DPS
$0.72
Dividend yield
0.3%
Payout ratio
3.3%

Financial health

How did Laboratory Corp Of America Holdings financials performed over time
LH's total assets is 108% greater than its total liabilities
Laboratory Corp Of America Holdings's current ratio has increased by 19% YoY and by 3.1% from the previous quarter
The quick ratio has grown by 14% YoY
The debt is 41% smaller than the equity
The company's equity rose by 7% YoY and by 4.4% QoQ
LH's debt to equity is down by 6% year-on-year and by 4.8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.